ClinicalTrials.gg
RecruitingNCT07865208Updated Oct 8, 2026

Measuring Plantar Pressures in Diabetic Patients With Lateral Forefoot Amputation

An observational study in Amputation, Diabetes Complications and Foot Complications, sponsored by Nanyang Technological University. Recruiting at 2 sites in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Nanyang Technological University · Observational

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
70
Ages
21 Years and older
Sex
All
01

Study summary

This study aims to understand how pressure is placed on the bottom of the foot when people walk after a lateral forefoot amputation (for example, removal of the 5th toe).

Podiatrists have noticed that people with this type of amputation often develop new foot wounds (ulcers) than other types of foot amputation. By measuring foot pressure during walking, we hope to:

  • Identify areas of high pressure ("hotspots")
  • Understand walking patterns after amputation
  • Identify biomechanical factors related to diabetic ulcers and foot amputations
  • Design better footwear and insoles in the future based on this information

The hypothesis is that people with lateral forefoot amputation have higher plantar pressures on the remaining parts of their foot.

Read the detailed description

Diabetes mellitus (DM) imposes an escalating healthcare burden in Singapore, where diabetes-related amputation rates remain among the highest globally, and are continuing to increase. An index foot amputation often marks the beginning, rather than the end, of DM foot complications, where between 16-65% of patients undergo further amputation within five years. Notably there is a higher rate of reamputation associated with lateral ray/toes amputation compared to medial or other ray amputations (39% vs 25-27%), and as high as 60% of patients experience repeat ulceration after a 5th ray amputation. This suggests a very high risk of complications specifically associated with lateral ray amputations.

The lateral foot is essential for absorbing ground reaction forces, maintaining balance, and generating propulsion. Consequently, the loss of the lateral rays destabilizes the foot, leading to secondary foot deformities and increased peak plantar pressures (PPP) occurring at remaining metatarsal or midfoot regions. These mechanical shifts are the primary drivers of the "amputation cascade", associated with ulceration and infection and thereafter repeated amputations. Therefore, understanding pressure patterns in diabetes patients is critical for understanding factors contributing to further foot complications, and pave the way for developing strategies against it .

Gap in the literature Despite the biomechanical importance of the lateral ray and a high rate of complication, there is a distinct lack of empirical data regarding the biomechanical features of this specific group. It is also unclear why literature almost only exist for 1st ray and transmetatarsal amputations. Based on preliminary data extracted from diabetic foot management clinic in a Podiatry clinic in a tertiary hospital, there is approximately 25-30% of patients with lateral ray amputations that are undergoing active treatment for diabetic foot complications, forming a substantial proportion of patients and burden on the health system.

This study seeks to compare plantar pressure patterns of patients with such lateral ray amputations to those with intact feet. Complementing the existing data of medial ray and transmetatarsal amputation, we hope that results from this study can enable better identification of individuals at higher risk, guide targeted offloading, and enhance postoperative surveillance in the short term. Long term wise, the findings may inform risk stratification tools, support the incorporation of plantar pressure data into diabetic foot monitoring programmes, and improve efficiency in reducing ulcerations and healthcare burden.

MAIN AIMS

  1. To quantify the magnitude of peak pressure in diabetic individuals following lateral forefoot amputation compared to age-, BMI- and neuropathy matched diabetic controls with intact feet.
  2. To map the anatomical locations of peak pressure points following the loss of the lateral rays.
  3. To develop a pressure pattern classification system by identifying and quantifying the prevalence of specific loading phenotypes

METHODOLOGY This study will use a cross-sectional observational design involving individuals with diabetes who have a lateral forefoot amputation, compared to an age , BMI and neuropathy-matched diabetic control group without amputations. Lateral amputations will include at least 5th toe amputation up to 3rd ray resection. A small prospective look at the reulceration rates for both groups of people will also be noted for any association to plantar pressure values.

The total use of the participant's time will be about 3 hours. The participant may need to visit the hospital up to 2 times. All of the study procedures can be completed in the same day if the participant prefer.

Clinical evaluation for all participants:

  • Age, sex
  • Height, Weight, Body-mass index (BMI)
  • Medical history, diabetes duration, HbA1c levels
  • Presence of peripheral arterial disease
  • Ulcer history (location, most recent recurrence)
  • Neuropathy assessment (using 10g monofilament)
  • Ankle, subtalar joint and midfoot joint range of motion measurements
  • Identification of pre-ulcerative callus locations.

Published studies on partial foot amputations report small, heterogeneous samples without effect size reporting. However, based on the mean difference and standard deviation published in these studies on ray amputations, a 95% confidence level with anticipated small sample variability, and power analysis (alpha = 0.05, Power = 0.80), the minimum required sample size is approximately 35 participants per group for a total of 70 participants

Protocol:

Demonstration and practice runs will be provided to familiarize participants with the walkway to reduce "targeting" (altering gait to hit the sensor). Participants will perform the second-step protocol, which has been identified as the most efficient method for obtaining reliable plantar pressure data in diabetic populations. For participants in the amputation group, the foot with the lateral amputation will be tested; while the matched controls will test with their dominant foot for standardization. Due to sensor size limitations, one step will be captured per pass on the walkway. Participants will complete a round trip to the starting point after each step. Steps will be collected continuously until 5-6 valid footprints are recorded for the foot of study in each trial. If the subject shows obvious gait deviations, abnormalities or "targeting", the steps will be considered invalid and excluded from analysis. 3 trials will be taken for each participant as per the common research practice, to generate a single representative dataset for each participant.

During the trial, participants will walk at their self-selected natural gait speed. While higher speeds typically correlate with increased peak pressures, a natural pace is prioritized to ensure patient safety and represent "real-world" routine circumstances. Walking speed will be calculated via video analysis of a 1m calibrated zone. These recordings will also be used to check for step validity and to note any gait features needed to explain observations. If there is a significant difference in gait speed between groups, it will be included as a covariate in later analysis.

Data processing A mask is applied over the pressure profile to demarcate between the anatomical locations of interest, namely toes, metatarsals, midfoot and heel. Using the built-in software in the pressure mat, the peak pressure values will be obtained for each region of interest on the mask. The dependent variables at each of the regions of interest will be recorded down for each participant and each trial to be used for statistical analysis. The pressure heatmap and Center of pressure line will be generated automatically by the software.

To ensure the integrity of the matching process, Descriptive Statistics (medians and interquartile ranges) will be used to summarize participant characteristics. To confirm that the control and amputation groups are effectively matched, Mann-Whitney U tests will be performed on age, BMI, and neuropathy scores as the data is likely to be non-normally distributed. Should significant differences arise in baseline variables (assessed from clinical evaluation), for example with gait speed or BMI, these will be formally treated as covariates in the primary analysis to isolate the effect of the amputation.

Given the expected non-normal distribution of plantar pressure data, a Generalized Linear Model (GLM) will be employed for group comparisons. This model allows for the inclusion of amputation status as the primary predictor while statistically controlling for potential confounders such as gait speed and BMI. This ensures that observed pressure elevations are attributable to altered foot morphology rather than gait speed or systemic factors. To maintain statistical stringency due to multiple anatomical regions of interest, a statistical corrections will be applied to the significance threshold (p-value) to reduce type 1 error.

Visual analytics, including plantar pressure heatmaps and center of pressure lines, will be generated as pictures from the software. Based on the location of the highest mean peak pressure, each foot will be classified into a pattern type named with the location of the peak pressure in the mask. If there is more than one location of equally high peak pressure, then it will be classified into a combination type. The proportion of feet in each pattern type in each group can then be calculated with simple statistics. These will provide clinical context to the quantitative data, illustrating shifts in the progression of the pressure wave throughout the stance phase in the presence of lateral ray resections.

To explore the biomechanical compensations that may be associated with high pressure at certain locations, Spearman's Rank Correlation will be used to assess the association between joint range of motion and the location of peak pressure. This non-parametric approach is to determine if restricted joint mobility in the ankle or midfoot is associated with the presence of peak pressure points at the metatarsals or plantar styloid area.

02

Conditions studied

  • Amputation
  • Diabetes Complications
  • Foot Complications
  • Biomechanics
  • Plantar Pressure

Keywords

  • plantar pressure
  • amputation
  • diabetic
  • lateral ray amputation
  • reulceration
  • biomechanics
  • foot
03

In context

Diabetes Complications

226 studies on the registry are indexed under Diabetes Complications; 51 are open to participants now.

This study's planned enrollment of 70 is below the median of 177 across 82 observational studies indexed under Diabetes Complications.

Browse Diabetes Complications studies →

Lead sponsor

Nanyang Technological University is the lead sponsor of 50 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Tertiary Public Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 21 years
  • Diagnosed with type 2 diabetes
  • Presence of a healed unilateral lateral forefoot amputation (at least 5th MPJ, up to any level including the 2nd toe and 2nd ray)
  • Ability to walk 10 meters unaided or with simple devices
  • Of sound mind to communicate, follow instructions, and consent independently
  • English or Chinese speaking

Exclusion criteria

Exclusion Criteria:

  • Amputation or partial amputation of the hallux and any bones higher than midfoot (cuneiforms, cuboid, navicular, calcaneus) on the affected foot
  • Major lower limb amputation (above ankle), of other leg
  • Severe gait impairments unrelated to foot amputation (stroke, foot drop etc)
  • Other foot deforming disease such as, but not limited to, charcot neuroarthropathy, rheumatoid arthritis etc.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Amputee

    21 years old or older Type 2 Diabetes Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick) Healed amputation on one foot involving at least the 5th toe (and any other toes but excluding the big toe)

  • Control

    21 years old or older Type 2 Diabetes no foot amputations Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick)

06

What researchers measure

Primary outcomes

  1. Plantar pressure

    \- Peak plantar pressure (PPP), which indicates the highest pressure recorded within a single stance phase.

    Time frame: upon enrolment

  2. Plantar pressure

    Mean peak pressure - obtained by averaging the pressures across several steps

    Time frame: upon enrolment

  3. Plantar pressure

    Pressure-time integral (PTI) measures the cumulative pressure exerted on a specific location over the period of the stance phase

    Time frame: upon enrolment

Secondary outcomes

  1. Plantar pressure

    Anatomical location of peak pressure based on pressure pattern heatmap (picture form)

    Time frame: upon enrolment

  2. Plantar pressure

    center of pressure line

    Time frame: upon enrolment

  3. prospective reulceration rate

    1-year reulceration rate

    Time frame: 1 year from enrolment

07

Study locations

2 of 2 sites recruiting
  • National University Hospital
    Singapore, 119074, Singapore
    • Xi Chen, Bachelor of Podiatry · Contact · chen_xi@nuhs.edu.sg · +6589732316
    • Vanessa Teo, Bachelor of Podiatry · Contact
    Recruiting
  • Ng Teng Fong General Hospital
    Singapore, 609606, Singapore
    Recruiting
08

References and documents

Publications

  • LeSavage LK, Hoffler HL, Evans JK, Blazek CD. Reulceration and Reoperation Rates After Central Ray Amputations: A Retrospective Study. J Foot Ankle Surg. 2023 May-Jun;62(3):482-486. doi: 10.1053/j.jfas.2022.11.014. Epub 2022 Nov 25. PubMed 36543723 ↗
  • Yammine K, Honeine M, Assi C. Should we resect more proximally? Outcomes of toe amputation versus ray resection in patients with infected diabetic ulcers and osteomyelitis. A preliminary study and new treatment algorithm. Foot Ankle Surg. 2023 Dec;29(8):593-596. doi: 10.1016/j.fas.2023.07.004. Epub 2023 Jul 17. PubMed 37482478 ↗
  • Lin JH, Jeon SY, Romano PS, Humphries MD. Rates and timing of subsequent amputation after initial minor amputation. J Vasc Surg. 2020 Jul;72(1):268-275. doi: 10.1016/j.jvs.2019.10.063. Epub 2020 Jan 21. PubMed 31980248 ↗
  • Izumi Y, Satterfield K, Lee S, Harkless LB. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care. 2006 Mar;29(3):566-70. doi: 10.2337/diacare.29.03.06.dc05-1992. PubMed 16505507 ↗
  • Cavanagh PR, Ulbrecht JS, Caputo GM. New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S6-S10. doi: 10.1002/1520-7560(200009/10)16:1+3.0.co;2-z. PubMed 11054880 ↗
  • Lockhart M, Dinneen SF, O'Keeffe DT. Plantar pressure measurement in diabetic foot disease: A scoping review. J Diabetes Investig. 2024 Aug;15(8):990-999. doi: 10.1111/jdi.14215. Epub 2024 Apr 18. PubMed 38634342 ↗
  • Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care. 1995 Nov;18(11):1460-2. doi: 10.2337/diacare.18.11.1460. PubMed 8722070 ↗
  • Elabd OM, El Nahass BG, Ibrahim MM. Pathological gait in partial foot amputation versus peripheral neuropathy. Gait Posture. 2023 Feb;100:41-48. doi: 10.1016/j.gaitpost.2022.11.064. Epub 2022 Dec 2. PubMed 36481645 ↗
  • Jarrett B, Cheung T, Oh E. The Lateral Column. Clin Podiatr Med Surg. 2020 Jan;37(1):53-60. doi: 10.1016/j.cpm.2019.08.005. PubMed 31735269 ↗
  • Hazari A, Maiya AG, Shivashankara KN, Agouris I, Monteiro A, Jadhav R, Kumar S, Shashi Kumar CG, Mayya SS. Kinetics and kinematics of diabetic foot in type 2 diabetes mellitus with and without peripheral neuropathy: a systematic review and meta-analysis. Springerplus. 2016 Oct 19;5(1):1819. doi: 10.1186/s40064-016-3405-9. eCollection 2016. PubMed 27812455 ↗
  • Borkosky SL, Roukis TS. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle. 2012;3. doi: 10.3402/dfa.v3i0.12169. Epub 2012 Jan 20. PubMed 22396832 ↗
  • Seckin MF, Ozcan C, Camur S, Polat O, Batar S. Predictive Factors and Amputation Level for Reamputation in Patients With Diabetic Foot: A Retrospective Case-Control Study. J Foot Ankle Surg. 2022 Jan-Feb;61(1):43-47. doi: 10.1053/j.jfas.2021.06.006. Epub 2021 Jun 19. PubMed 34253432 ↗
  • Wong KL, Nather A, Chanyarungrojn AP, Shen L, Ong TE, Elangovan RD, Lim CT. Clinical outcomes of ray amputation in diabetic foot patients. Ann Acad Med Singap. 2014 Aug;43(8):428-32. No abstract available. PubMed 25244993 ↗
  • Borg I, Mizzi S, Formosa C. Plantar Pressure Distribution in Patients with Diabetic Peripheral Neuropathy and a First-Ray Amputation. J Am Podiatr Med Assoc. 2018 May;108(3):225-230. doi: 10.7547/16-021. PubMed 29932753 ↗

Study documents

  • Informed consent form · Sep 12, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Institution policy disallow sharing of patient data outside of organisation. Only anonymised results for publishing are allowed

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Oct 2027, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2026
First posted
Oct 8, 2026
StartEst.
Nov 27, 2026
Primary completionEst.
Oct 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07865208
Lead sponsor
Nanyang Technological University
Responsible party
Chen Xi (Senior Podiatrist, Nanyang Technological University) — Principal investigator
First posted
Oct 8, 2026
Start date
Nov 27, 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Xi Chen, Bachelor of Podiatry
Contact
chen_xi@nuhs.edu.sg
+6589732316

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion